This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Joseph Aisner, MD; Don Morris, MD; E. George Elias, MD, PhD; Peter H. Wiernik, MD

Arch Surg. 1982;117(7):882-887.

Abstract
• Patients with unresectable tumors require local treatment of ulcerating or fungating masses. Chemotherapy can shrink the tumor, permitting mastectomy. Continued chemotherapy treats the overt or micrometastases. Of 27 patients with bulky primary tumors, 15 had overt metastases and 12 did not. Thirteen of the 27 had inflammatory carcinoma. After three to four chemotherapy courses, 24 patients were operable, and 22 underwent mastectomy. Eighteen of the 22 had closure without skin grafts. In three, disease recurred at the primary site, and in five at both primary and distal sites. Preoperatively, one patient (4%) achieved complete response and 19 (70%) achieved partial response. After mastectomy, five patients with metastases in stable partial response further responded to chemotherapy and achieved complete response. Chemotherapy with adjuvant mastectomy is technically feasible and offers the possibility of improved duration of survival in some patients.

(Arch Surg 1982;117:882-887)

Author Affiliations
From the Section of Medical Oncology, Baltimore Cancer Research Center, University of Maryland Hospital (Drs Aisner and Wiernik), and the Oncology Program, Department of Surgery, University of Maryland School of Medicine (Drs Morris and Elias), Baltimore.

Footnotes
Accepted for publication Nov 16, 1981.

Reprint requests to Baltimore Cancer Research Center, 22 S Greene St, Baltimore, MD 21201 (Dr Aisner).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer
Yeh et al.
Am. J. Roentgenol. 2005;184:868-877.
ABSTRACT | FULL TEXT  

Invasive Ductal Breast Carcinoma Response to Neoadjuvant Chemotherapy: Noninvasive Monitoring with Functional MR Imaging— Pilot Study
Delille et al.
Radiology 2003;228:63-69.
ABSTRACT | FULL TEXT  

Locally Advanced Breast Cancer
Valero et al.
The Oncologist 1996;1:8-17.
ABSTRACT | FULL TEXT  

Neoadjuvant Chemotherapy Before Definitive Treatment for Stage III Carcinoma of the Breast
Schwartz et al.
Arch Surg 1987;122:1430-1434.
ABSTRACT  

Multimodal Therapy for Locally Advanced Breast Cancer
Morrow et al.
Arch Surg 1986;121:1291-1296.
ABSTRACT